Discover 2,017 paid clinical trials in Michigan. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Michigan offers access to numerous clinical research opportunities for both healthy volunteers interested in paid studies and those with specific health conditions. Research hubs in Detroit, Grand Rapids, and Ann Arbor are enrolling participants, providing access to innovative treatments and personalized care options.
Filter
1
Filter results
Results: 2,017
Focused Orticumab Research for Treating Inflammation in Coronary Arteries
Location: Baltimore MD, Boca Raton FL, Midland MI, Richmond IN,
Sponsor: Abcentra
Sex: All
Age: 18+
Code: NCT06927739
Phase 2, Recruiting
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
for
Prostate Cancer
Location: Scarborough ME, Boston MA, The Bronx NY, New York NY,
Sponsor: Novartis Pharmaceuticals
Sex: Male
Age: 18 - 70+
Code: NCT06855277
Phase 3, Recruiting
Study of the Efficacy and Safety of ICP-332 in Participants With Prurigo Nodularis
for
Prurigo Nodularis (PN)
Location: Portsmouth NH, Miami FL, Sweetwater FL,
Sponsor: Beijing InnoCare Pharma Tech Co., Ltd.
Sex: All
Age: 18 - 70+
Code: NCT07236099
Phase 2, Recruiting
A Study of the TheraBionic P1 Device in Breast Cancer
for
Breast Cancer Stage I, Breast Cancer Stage II,
Location: Port Huron MI, Detroit MI, Farmington Hills MI,
Sponsor: Barbara Ann Karmanos Cancer Institute
Sex: Female
Age: 22+
Code: NCT07218432
Recruiting
A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
for
Ovarian Cancer
Location: Boston MA, Worcester MA, New York NY, Hackensack NJ,
Sponsor: Incyte Corporation
Sex: Female
Age: 18 - 70+
Code: NCT07023627
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Vascular Trial Associated Registry Pilot
for
Peripheral Arterial Disease
Location: Detroit MI, Grand Rapids MI
Sponsor: Corewell Health West
Sex: All
Age: 45+
Code: NCT07076082
Recruiting
A Study of APG-3288 in Relapsed/Refractory Blood Cancers
for
Relapsed/Refractory Hematological Malignancies,
Location: East Brunswick NJ, Jacksonville FL, Grand Rapids MI,
Sponsor: Ascentage Pharma Group Inc.
Sex: All
Age: 18+
Code: NCT07424833
Phase 1, Recruiting
A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)
Location: St. John's, Halifax, Bangor ME, Scarborough ME,
Sponsor: Children's Oncology Group
Sex: All
Age: 1 - 30
Code: NCT03126916
Phase 3, Recruiting
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
for
Ulcerative Colitis
Location: Providence RI, Worcester MA, New Haven CT, Maspeth NY,
Sponsor: Sanofi
Sex: All
Age: 16 - 70+
Code: NCT07184996
Phase 3, Recruiting
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
for
Ulcerative Colitis
Location: Providence RI, Worcester MA, Maspeth NY, New York NY,
Sponsor: Sanofi
Sex: All
Age: 16 - 70+
Code: NCT07185009
Phase 3, Recruiting
Tailoring a Home Supervision Intervention for Latinx Caregivers
for
Healthy
Location: Kalamazoo MI
Sponsor: Western Michigan University
Sex: All
Age: 18 - 70+
Code: NCT07203612
Recruiting
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
for
Crohn's Disease
Location: Boston MA, Providence RI, Worcester MA, New Haven CT,
Sponsor: Sanofi
Sex: All
Age: 16 - 70+
Code: NCT07184931
Phase 3, Recruiting
TLN-372 in Advanced KRAS Mutant Solid Tumors
for
KRAS Mutant Solid Tumors
Location: Boston MA, New York NY, Toronto, Grand Rapids MI,
Sponsor: Treeline Biosciences, Inc.
Sex: All
Age: 18+
Code: NCT07204340
Phase 1, Recruiting
A Study to Learn About the Investigational Drug Rinzimetostat (ORIC-944) in Patients With mCRPC Who Were Previously Treated With Abiraterone Acetate (Himalayas-1)
for
Metastatic Castration Resistant Prostate Cancer
Location: Myrtle Beach SC, Coral Springs FL, Charlotte NC,
Sponsor: ORIC Pharmaceuticals
Sex: Male
Age: 18+
Code: NCT07723248
Phase 3, Recruiting
Developing a Self-Management Intervention to Improve Health Outcomes for Patients With Inflammatory Bowel Disease